Pfizer profit before tax down marginally to Rs 173 crore in June quarter
Revenue stood at Rs 514.89 crore against Rs 544.40 crore for the same period a year ago
 "Pfizer profit before tax down marginally to Rs 173 crore in June quarter")
premium
Pfizer posted a profit before tax of Rs 173.3 crore for the June quarter of FY21, a negligible decline of 0.8 per cent when compared with the corresponding quarter of the previous financial year.
The drugmaker had posted a profit before tax of Rs 174.91 crore in June quarter of FY20. Revenue stood at Rs 514.89 crore against Rs 544.40 crore for the same period a year ago.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%